Federated Hermes’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,915
| Closed | -$719K | – | 2378 |
|
|
2021
Q2 | $719K | Sell |
3,915
-1,036
| -21% | -$178K | ﹤0.01% | 1411 |
|
|
2021
Q1 | $757K | Sell |
4,951
-4,696
| -49% | -$726K | ﹤0.01% | 1470 |
|
|
2020
Q4 | $1.51M | Sell |
9,647
-196,153
| -95% | -$25.2M | ﹤0.01% | 1169 |
|
|
2020
Q3 | $23.6M | Buy |
205,800
+57,518
| +39% | +$6.21M | 0.06% | 377 |
|
|
2020
Q2 | $16.6M | Sell |
148,282
-47,150
| -24% | -$5.01M | 0.04% | 429 |
|
|
2020
Q1 | $17.5M | Buy |
195,432
+84,025
| +75% | +$8.25M | 0.05% | 363 |
|
|
2019
Q4 | $12M | Buy |
111,407
+22,094
| +25% | +$2.36M | 0.03% | 555 |
|
|
2019
Q3 | $8.75M | Buy |
89,313
+85,934
| +2,543% | +$9.69M | 0.02% | 610 |
|
|
2019
Q2 | $442K | Sell |
3,379
-13,278
| -80% | -$1.71M | ﹤0.01% | 1456 |
|
|
2019
Q1 | $2.25M | Buy |
16,657
+2,560
| +18% | +$318K | 0.01% | 1010 |
|
|
2018
Q4 | $1.37M | Buy |
14,097
+4,559
| +48% | +$539K | ﹤0.01% | 1174 |
|
|
2018
Q3 | $1.33M | Sell |
9,538
-6,278
| -40% | -$788K | ﹤0.01% | 1259 |
|
|
2018
Q2 | $1.96M | Sell |
15,816
-10,755
| -40% | -$1.26M | 0.01% | 1024 |
|
|
2018
Q1 | $2.96M | Sell |
26,571
-167,443
| -86% | -$20M | 0.01% | 803 |
|
|
2017
Q4 | $23.2M | Sell |
194,014
-376,034
| -66% | -$45.8M | 0.07% | 227 |
|
|
2017
Q3 | $80M | Sell |
570,048
-60,816
| -10% | -$8.26M | 0.23% | 90 |
|
|
2017
Q2 | $76.8M | Buy |
630,864
+66,880
| +12% | +$7.78M | 0.22% | 89 |
|
|
2017
Q1 | $68.4M | Sell |
563,984
-14,196
| -2% | -$1.83M | 0.2% | 98 |
|
|
2016
Q4 | $70.7M | Buy |
578,180
+52,709
| +10% | +$6.45M | 0.21% | 91 |
|
|
2016
Q3 | $64.4M | Buy |
525,471
+25,002
| +5% | +$3.22M | 0.19% | 99 |
|
|
2016
Q2 | $58.4M | Buy |
500,469
+28,721
| +6% | +$4.08M | 0.17% | 101 |
|
|
2016
Q1 | $65.7M | Buy |
471,748
+3,260
| +0.7% | +$479K | 0.2% | 90 |
|
|
2015
Q4 | $89.4M | Buy |
468,488
+29,627
| +7% | +$5.18M | 0.28% | 72 |
|
|
2015
Q3 | $68.6M | Buy |
438,861
+58,175
| +15% | +$10.6M | 0.22% | 87 |
|
|
2015
Q2 | $68.8M | Buy |
380,686
+337,070
| +773% | +$58.2M | 0.21% | 95 |
|
|
2015
Q1 | $7.56M | Sell |
43,616
-114,268
| -72% | -$20.7M | 0.02% | 510 |
|
|
2014
Q4 | $29.2M | Buy |
157,884
+3,172
| +2% | +$588K | 0.09% | 213 |
|
|
2014
Q3 | $25.7M | Sell |
154,712
-2,310
| -1% | -$379K | 0.08% | 233 |
|
|
2014
Q2 | $24.5M | Buy |
157,022
+20,151
| +15% | +$3.18M | 0.08% | 249 |
|
|
2014
Q1 | $20.8M | Buy |
136,871
+79,952
| +140% | +$12.7M | 0.07% | 272 |
|
|
2013
Q4 | $7.57M | Buy |
56,919
+2,701
| +5% | +$324K | 0.03% | 520 |
|
|
2013
Q3 | $6.3M | Buy |
54,218
+622
| +1% | +$68.2K | 0.02% | 510 |
|
|
2013
Q2 | $4.94M | Buy |
+53,596
| New | +$5.16M | 0.02% | 584 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM